T0	Outcomes 475 497	cellular immune system
T1	Outcomes 902 1091	concentration of plasma-TNF-alpha, subpopulations of blood mononuclear cells, the proliferative responses nor the natural killer (NK), and lymphokine activated killer (LAK) cell activities.
T2	Outcomes 1152 1214	weight, temperature, well being, or tiredness of the subjects.
T3	Outcomes 1257 1287	gastrointestinal side effects.
T4	Outcomes 1375 1432	blood mononuclear cell (BMNC) proliferative responses, NK
T5	Outcomes 1438 1458	LAK cell activities.